Top Markets
#1 Glidr Glidr +51.75%
#2 Akedo Akedo +49.56%
#3 DOVU DOVU +49.39%
#4 Velvet Velvet +44.04%
#5 Black Phoenix Black Phoenix +34.54%
#6 τemplar τemplar +23.14%
#7 Cross Cross +18.32%
#8 Ribbita by Virtuals Ribbita by Virtuals +17.09%
#9 Cap Cap +16.96%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +15.04%
Coin of the day
Glidr Glidr
設定
言語
日本
通貨
USD
テーマ
Copland Road Capital Corporation Copland Road Capital Corporation

Copland Road Capital Corporation

CRCC
株式のランク #38328
Operating as a principal investment firm, Copland Road Capital Corporation,... Operating as a principal investment firm, Copland Road Capital Corporation, previously known as Nabis Holdings Inc., dedicates its capital deployment to the cannabis industry. The company primarily targets investment opportunities within the United States. Its strategy involves acquiring controlling (majority) stakes in the businesses it finances and often prefers that selling entities accept a significant part of their payment in the form of company equity. Established in 2002, Copland Road Capital Corporation is headquartered in Vancouver, Canada, and also maintains an office in Toronto.
株価
$0.0954118
最終同期: 2026-02-23
時価総額
$1.06M
変化（1日）
0.00%
変化（1年）
-24.69%
国
CA
取引 Copland Road Capital Corporation (CRCC)

カテゴリー

Healthcare
Copland Road Capital Corporation（CRCC）のP/S比率
2026 時点のP/S比率 TTM: 0
Copland Road Capital Corporation の最新の財務報告および株価によると、現在のP/S比率（TTM）は 0 です。2026 年末時点でのP/S比率は 0 でした。
Copland Road Capital Corporation の P/S 比率の履歴（2026 ～ 2026）
各年末時点のP/S比率
年 P/S比率 変化
提供された日付のデータは十分ではありません。
同業他社のP/S比率
企業 P/S比率 P/S比率の差 国
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
- -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
- -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
- -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
- -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
8.17 -
IN